OMIP ‐ 121 : Immune Phenotyping of Canine Peripheral Leukocytes by Mass Cytometry
Cytometry Part A · 2026-06 · 109 (6) · 393-412
DOI: 10.1002/cyto.a.70040 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cytometry Part A, online erschienen am 15.06.2026. Verfasst von Huyen Thuc Tran Luong und 5 weiteren Autor:innen. Beteiligte Einrichtung: National Cytometry Platform, Translational Medicine Operations Hub, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg. Hauptthemen laut MEDLINE: Immunophenotyping, Flow Cytometry, Leukocytes, Mononuclear, Leukocytes. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Luxembourg National Research Fund (FNR), Javna Agencija za Raziskovalno Dejavnost RS, FWO WEAVE.
Abstract (Originalsprache)
Dogs are a critical non‐rodent species used in preclinical safety studies, particularly, in the pharmaceutical field, due to their physiological, metabolic, and immunological similarities to humans. As such, immunophenotyping of canine peripheral blood mononuclear cells (PBMCs) plays a crucial role in translational research, immune monitoring, and safety evaluations in drug development. However, the limited availability of canine‐specific antibodies restricts detailed and accurate immune profiling, which is essential for advancing safety evaluations in drug development. To address this challenge, we developed a 15‐marker panel for comprehensive mass cytometry‐based immunophenotyping of cryopreserved canine PBMCs. This panel encompasses major leukocyte subsets, including B cells, CD4+ T helper cells, regulatory T cells, CD8+ cytotoxic T cells, memory T cell subsets, natural killer T cells, natural killer cells, dendritic cells, CD4+ monocytes, classical monocytes, and neutrophils. We utilized both extracellular and intracellular markers to facilitate in‐depth immune profiling, despite the limited availability of canine‐specific antibodies. The panel was thoroughly optimized in terms of marker selection, antibody clone validation, and metal isotope pairing. Additionally, by the use of mass cytometry, several channels remain unoccupied, providing flexibility for future panel expansion.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- National Cytometry Platform, Translational Medicine Operations Hub, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg.
- Faculty of Science, Technology and Medicine, University of Luxembourg, Esch-sur-Alzette, Luxembourg.
- Small Animal Department, Faculty of Veterinary Medicine, Ghent University, Ghent, Belgium.
- Laboratory for Environmental and Life Sciences, University of Nova Gorica, Nova Gorica, Slovenia.
ORCID-Profile: Sofie Vercammen, Antonio Cosma
Förderung
- Luxembourg National Research Fund (FNR)
- Javna Agencija za Raziskovalno Dejavnost RS
- FWO WEAVE
- Fonds National de la Recherche Luxembourg
- The Slovenian Research and Innovation Agency
Zitieren
APA
Luong, H. T. T., Revets, D., Vercammen, S., de Marco, A., de Rooster, H., & Cosma, A. (2026). OMIP ‐ 121 : Immune Phenotyping of Canine Peripheral Leukocytes by Mass Cytometry. Cytometry Part A, 109(6), 393-412. https://doi.org/10.1002/cyto.a.70040
Vancouver
Luong HTT, Revets D, Vercammen S, de Marco A, de Rooster H, Cosma A. OMIP ‐ 121 : Immune Phenotyping of Canine Peripheral Leukocytes by Mass Cytometry. Cytometry Part A. 2026;109(6):393-412. doi:10.1002/cyto.a.70040
BibTeX
@article{Luong2026,
author = {Luong, Huyen Thuc Tran and Revets, Dominique and Vercammen, Sofie and de Marco, Ario and de Rooster, Hilde and Cosma, Antonio},
title = {OMIP ‐ 121 : Immune Phenotyping of Canine Peripheral Leukocytes by Mass Cytometry},
journal = {Cytometry Part A},
year = {2026},
volume = {109},
number = {6},
pages = {393--412},
doi = {10.1002/cyto.a.70040}
}
EUVIMED